FAM225A and nasopharyngeal carcinoma: In nasopharyngeal carcinoma, lncRNA FAM225A acts as a ceRNA, sequestering miR-590-3p and miR-1275, thus activating FAK/PI3K/Akt signaling; in this scenario, m6A modification contributes to this mechanism by increasing the lncRNA FAM225A stability [202].